Matterport (MTTR) Announces Redemption of Public Warrants
by Nicholas Alan Clayton on 2021-12-15 at 7:54am

Matterport (NASDAQ:MTTR) announced this morning that it will redeem all outstanding warrants and warrantholders have until 5 pm ET, January 14, 2022 to exercise them.

The company, which completed its combination with Gores VI in July, has been a relative bright spot among de-SPACs in the current market, hitting a high of $33.48 on November 29 and generally trading above $20 since Halloween.

As such, it has long met the requirements of the warrant agreement to trade at or above $18 for 20 of 30 trading days at least three days before calling warrants. Warrantholders may exchange the 1/5 warrants originally included in Gores VI’s IPO for shares at a price of $11.50 per share.

Any of the 6,900,000 outstanding public warrants that remain unexercised after the deadline will be void, and those holders will be entitled to receive only the redemption price of $0.01 per warrant.

Gores VI and Matterport initially announced their $2.3 billion combination on February 8. Matterport provides spatial information on physical spaces to real estate and other industries and has created the largest spatial data library in the world.

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

by Nicholas Alan Clayton on 2024-04-16 at 7:58am

At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...

by Nicholas Alan Clayton on 2024-04-15 at 3:47pm

AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved